Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318955566> ?p ?o ?g. }
- W4318955566 endingPage "106126" @default.
- W4318955566 startingPage "106126" @default.
- W4318955566 abstract "Current COVID-19 vaccines have been associated with a decline in infection rates, prevention of severe disease, and a decrease in mortality rates. However, SARS-CoV-2 variants are continuously evolving, and development of new accessible COVID-19 vaccines is essential to mitigate the pandemic. Here, we present data on preclinical studies in mice of a receptor-binding domain (RBD)-based recombinant protein vaccine (PHH-1V) consisting of an RBD fusion heterodimer comprising the B.1.351 and B.1.1.7 SARS-CoV-2 variants formulated in SQBA adjuvant, an oil-in-water emulsion. A prime-boost immunisation with PHH-1V in BALB/c and K18-hACE2 mice induced a CD4+ and CD8+ T cell response and RBD-binding antibodies with neutralizing activity against several variants, and also showed a good tolerability profile. Significantly, RBD fusion heterodimer vaccination conferred 100% efficacy, preventing mortality in SARS-CoV-2 infected K18-hACE2 mice, but also reducing Beta, Delta and Omicron infection in lower respiratory airways. These findings demonstrate the feasibility of this recombinant vaccine strategy." @default.
- W4318955566 created "2023-02-03" @default.
- W4318955566 creator A5001712199 @default.
- W4318955566 creator A5002445997 @default.
- W4318955566 creator A5004140307 @default.
- W4318955566 creator A5007312733 @default.
- W4318955566 creator A5015893529 @default.
- W4318955566 creator A5017341804 @default.
- W4318955566 creator A5020404643 @default.
- W4318955566 creator A5021377937 @default.
- W4318955566 creator A5028130303 @default.
- W4318955566 creator A5029466198 @default.
- W4318955566 creator A5029705489 @default.
- W4318955566 creator A5031165814 @default.
- W4318955566 creator A5033555145 @default.
- W4318955566 creator A5037744581 @default.
- W4318955566 creator A5039657513 @default.
- W4318955566 creator A5040563081 @default.
- W4318955566 creator A5041155412 @default.
- W4318955566 creator A5044119355 @default.
- W4318955566 creator A5044612324 @default.
- W4318955566 creator A5047749880 @default.
- W4318955566 creator A5048164360 @default.
- W4318955566 creator A5049257586 @default.
- W4318955566 creator A5049972466 @default.
- W4318955566 creator A5052344820 @default.
- W4318955566 creator A5055796732 @default.
- W4318955566 creator A5056187765 @default.
- W4318955566 creator A5058799787 @default.
- W4318955566 creator A5059811127 @default.
- W4318955566 creator A5062815071 @default.
- W4318955566 creator A5063322197 @default.
- W4318955566 creator A5065831738 @default.
- W4318955566 creator A5066647505 @default.
- W4318955566 creator A5068883375 @default.
- W4318955566 creator A5069696636 @default.
- W4318955566 creator A5073132494 @default.
- W4318955566 creator A5074676096 @default.
- W4318955566 creator A5075577918 @default.
- W4318955566 creator A5076788962 @default.
- W4318955566 creator A5077398154 @default.
- W4318955566 creator A5078514449 @default.
- W4318955566 creator A5079245484 @default.
- W4318955566 creator A5079680339 @default.
- W4318955566 creator A5080547971 @default.
- W4318955566 creator A5084072562 @default.
- W4318955566 creator A5087721770 @default.
- W4318955566 creator A5089557224 @default.
- W4318955566 date "2023-03-01" @default.
- W4318955566 modified "2023-10-17" @default.
- W4318955566 title "Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2" @default.
- W4318955566 cites W1975580333 @default.
- W4318955566 cites W1976499671 @default.
- W4318955566 cites W2018544077 @default.
- W4318955566 cites W2041647537 @default.
- W4318955566 cites W2075934385 @default.
- W4318955566 cites W2102235987 @default.
- W4318955566 cites W2160868144 @default.
- W4318955566 cites W2404280981 @default.
- W4318955566 cites W2750464792 @default.
- W4318955566 cites W2952045272 @default.
- W4318955566 cites W3011447664 @default.
- W4318955566 cites W3017434281 @default.
- W4318955566 cites W3024765662 @default.
- W4318955566 cites W3046463683 @default.
- W4318955566 cites W3081892744 @default.
- W4318955566 cites W3083406432 @default.
- W4318955566 cites W3083773456 @default.
- W4318955566 cites W3086125063 @default.
- W4318955566 cites W3093810077 @default.
- W4318955566 cites W3103590655 @default.
- W4318955566 cites W3105914759 @default.
- W4318955566 cites W3106917004 @default.
- W4318955566 cites W3117730334 @default.
- W4318955566 cites W3119909661 @default.
- W4318955566 cites W3123053754 @default.
- W4318955566 cites W3124477881 @default.
- W4318955566 cites W3127185691 @default.
- W4318955566 cites W3127852352 @default.
- W4318955566 cites W3133277826 @default.
- W4318955566 cites W3133745198 @default.
- W4318955566 cites W3142966103 @default.
- W4318955566 cites W3149102402 @default.
- W4318955566 cites W3150725587 @default.
- W4318955566 cites W3152885607 @default.
- W4318955566 cites W3160661183 @default.
- W4318955566 cites W3169651048 @default.
- W4318955566 cites W3171309671 @default.
- W4318955566 cites W3177828909 @default.
- W4318955566 cites W3184341293 @default.
- W4318955566 cites W3199631570 @default.
- W4318955566 cites W3211172645 @default.
- W4318955566 cites W4200600673 @default.
- W4318955566 cites W4220807057 @default.
- W4318955566 cites W4220850641 @default.
- W4318955566 cites W4221063567 @default.
- W4318955566 cites W4225422665 @default.
- W4318955566 doi "https://doi.org/10.1016/j.isci.2023.106126" @default.